14 pages of guff to get to 730k in receipts.....for all the technology savvy that Pointerra clain to have with their software, they can't seem to work out how invoicing & cashflow works (surely just pay ~$200 per month for Xero and it will automatically remind you to invoice your clients)
the only real surprise for most shareholders is that there was no major 'deal' announced ahead of the 4C and that there has not been a capital raise (well still 2.9m in the bank so there is a possibility of something to look forward to)
I still recall all the talk of the US Utility sector delaying programs for a number of years (??? I never believed that little bit of nonsense that Olsen jumped on), and now it has been unshackled......hard to believe that with 700k in revenues
when you consider that out of the $730k, $404k went to AWS etc, then it's a pretty shocking metric that they bought in ~$300k (so USD200k) in revenues
- Forums
- ASX - By Stock
- 3DP
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
3DP
pointerra limited
Add to My Watchlist
12.8%
!
5.3¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.3¢ |
Change
0.006(12.8%) |
Mkt cap ! $42.66M |
Open | High | Low | Value | Volume |
4.6¢ | 5.5¢ | 4.6¢ | $78.98K | 1.597M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 94523 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 9803 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 280000 | 0.052 |
1 | 12500 | 0.051 |
1 | 300000 | 0.050 |
1 | 100000 | 0.049 |
2 | 121427 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 9803 | 1 |
0.059 | 17126 | 1 |
0.060 | 10944 | 2 |
0.062 | 6210 | 1 |
0.064 | 25000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online